Trending Articles

article thumbnail

Cassidy calls to delay meeting of CDC’s vaccine panel in challenge to RFK Jr.

STAT

WASHINGTON — A key Senate health leader is calling for this week’s meeting of the panel of vaccine advisers handpicked by Health and Human Services Secretary Robert F. Kennedy Jr. to be delayed, citing their lack of experience and potential bias against some vaccines. “Although the appointees to [the Advisory Committee on Immunization Practices] have scientific credentials, many do not have significant experience studying microbiology, epidemiology or immunology.

Vaccines 364
article thumbnail

How a Big Pharma veteran looks to stand out in biotech as a unique ‘drug hunter’

PharmaVoice

J&J’s former head of R&D, now CEO of Parabilis Medicines, aims to remain above the biotech fray by taking on unique targets from which others have steered clear.

130
130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

FDA to speed reviews for drugs supporting ‘national interests’

PharmaVoice

A new pilot program announced by FDA Commissioner Dr. Martin Makary would award vouchers that could cut drug reviews to one or two months — but only for products that meet a special criteria.

219
219
article thumbnail

Gene therapy faces fresh uncertainty as two more top FDA officials depart

BioPharma Dive

The reported dismissal of high-ranking CBER officials Nicole Verdun and Rachael Anatol resurfaced lingering concerns about how gene therapies will be regulated under new FDA leadership.

124
124
article thumbnail

Navigating Payroll Compliance: Future-Proofing Payroll in an Evolving Regulatory Landscape

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

article thumbnail

NEC and Chugai Pharmaceutical use AI to reduce drug combination prediction time for cancer treatments

Express Pharma

NEC Corporation, in collaboration with Chugai Pharmaceutical, has conducted an experiment using artificial intelligence (AI) to predict drug combinations that may improve the effectiveness of certain cancer treatments. According to the companies, the AI system may reduce the time required to produce these predictions by approximately 50 per cent when compared to Chugai’s conventional methods.

96

More Trending

article thumbnail

STAT+: Gilead won U.S. approval for HIV prevention shot, but when will low-income countries gain sufficient access?

STAT

Now that Gilead Sciences has won U.S. regulatory approval for its groundbreaking HIV prevention drug , the company has another hurdle to clear — ensuring the medicine can be accessed in low-income countries where the disease remains a stubborn problem. As far as Gilead is concerned, the groundwork exists to meet that goal. Last October, the drugmaker reached voluntary licensing agreements to eventually make lenacapavir available in 120 mostly low- and lower-middle-income countries.

article thumbnail

Megablockbusters are the holy grail. Here’s how drugmakers are getting there.

PharmaVoice

Skip to main content CONTINUE TO SITE ➞ Dont miss the most important voices in pharma Let PharmaVoices free newsletter keep you informed on what industry leaders are saying, straight from your inbox. By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime. Voices Q&A Profiles Biotech Spotlight First 90 Days Opinions Topics Biotech Commercialization Leadership Manufacturing Patient Pharma Policy & Regulation Research & Deve

Diabetes 147
article thumbnail

FDA approves twice-yearly shot of Gilead drug for HIV prevention

BioPharma Dive

The clearance ushers in a closely-watched launch for Gilead, which aims to show a long-acting injection can upend a market dominated by oral medicines.

115
115
article thumbnail

People With Severe Diabetes Are Cured in Small Trial of New Drug

NY Times

Most in a small group of patients receiving a stem cell-based infusion no longer needed insulin, but the drug may not suit those with more manageable type 1 diabetes.

Diabetes 112
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

‘HIV-ending’ drug could be made for just $25 per patient a year, say researchers

The Guardian - Pharmaceutical Industry

As regulator prepares to approve lenacapavir in the US, campaigners are urging the manufacturer, Gilead, to make it ‘available and affordable for all who need it’ A drug with the potential to “end the HIV pandemic” will launch in the US this week – as a new study reveals it could be sold for 1,000 times less than its possible price tag. Lenacapavir, given as a twice-yearly injection, can prevent someone from being infected with HIV, according to clinical trial results.

109
109
article thumbnail

STAT+: Off-the-shelf stem cell therapy for type 1 diabetes continues to show positive results

STAT

Twelve people with type 1 diabetes who received an investigational off-the-shelf stem cell therapy were able to produce their own insulin and keep healthy blood glucose levels for at least one year, Vertex Pharmaceuticals said Friday. After three months, none of them suffered severe bouts of low blood sugar. After 12 months, out of the 12 participants, 10 no longer needed to inject insulin.

Diabetes 359
article thumbnail

Call to embed community pharmacists in multidisciplinary palliative care teams

The Pharmacist

Community pharmacists must be embedded in multidisciplinary palliative care teams in rural communities and have access to shared care plans and health records, a new report by Hospice UK has urged. The report, called Bringing care closer to home: Improving palliative care in remote, rural and island communities, has highlighted the critical role of community […] The post Call to embed community pharmacists in multidisciplinary palliative care teams appeared first on The Pharmacist.

85
article thumbnail

CNS innovator oligonucleotide licensing value surges by 339% to $2.8 billion in 2024, reveals GlobalData

Express Pharma

Innovator oligonucleotide-based drugs targeting central nervous system (CNS) disorders have seen a remarkable 339 per cent increase in licensing agreement deal value, rising from $640 million in 2023 to $2.81 billion in 2024, according to GlobalData. Oligonucleotides, which are short synthetic DNA or RNA strands, are utilised in precision medicine to selectively bind to disease-causing genetic sequences, offering targeted therapeutic options for complex diseases.

article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

2025 PharmaTimes Clinical Researcher of the Year

Pharma Times

Enter this year's famous competition

111
111
article thumbnail

Opinion: Six former CDC vaccine advisory committee chairs warn: U.S. risks losing access to life-saving immunizations

STAT

As former chairs of the CDC’s Advisory Committee on Immunization Practices ( ACIP ), we are deeply alarmed by the growing politicization of vaccines — a public health innovation that has saved 154 million lives globally. While politicization of science is not new, the escalating distrust in science across the political spectrum, and its intrusion into the vaccine ecosystem, now threatens the very infrastructure that has long protected Americans from infectious diseases.

article thumbnail

Prothena to lay off majority of staff; Zealand shares obesity drug data

BioPharma Dive

Prothena will cut 63% of its workforce and evaluate a “range of business options.” Elsewhere, Zealand revealed data for a dual-acting obesity drug and Biogen kicked off a new late-stage trial.

109
109
article thumbnail

The Waste Musk Created

NY Times

Aid cuts have reached a level where they undermine our national interest as well as corrode our souls.

article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Sheffield scientists and AstraZeneca develop new machine learning model for inverse protein folding

Express Pharma

In a study published in Nature Machine Intelligence , researchers from the University of Sheffield, in collaboration with AstraZeneca and the University of Southampton, have developed a machine learning framework that demonstrates improved accuracy in inverse protein folding compared to existing methods. Inverse protein folding involves identifying amino acid sequences that form a desired 3D protein structure.

article thumbnail

The Top 15 Specialty Pharmacies of 2024: How PBMs, Health Systems, and Independents Are Shaping the Market (rerun)

Drug Channels

This week, I’m rerunning some popular posts while I prepare for Friday’s live video webinar: What’s Next for Retail Pharmacy: Data, Debate, and Disruption. I’ll be joined by special guest Antonio Ciaccia, CEO of 46brooklyn Research, and President of 3 Axis Advisors. Click here to see the original post from April 2025. Drug Channels Institute’s (DCI’s) latest analysis reveals that PBM-affiliated specialty pharmacies continue to dominate the dispensing of specialty drugs.

article thumbnail

STAT+: Top drug regulator is retiring as FDA departures mount

STAT

WASHINGTON — Jacqueline Corrigan-Curay, the top drug regulator at the Food and Drug Administration, is retiring from the agency in July.  Corrigan-Curay, who took over as acting director of the Center for Drug Evaluation and Research in January, broke the news to staff in an email shared with STAT. She said she decided to leave the agency after taking a recent vacation, and thanked staff for their “unwavering support, especially during recent challenging times.

article thumbnail

How new medicines become available on the NHS

The Pharmacist

New medicines can transform the treatment and prevention of disease, improving – and in many cases saving – lives. But no health system has unlimited resources. This creates a political and technical challenge for governments and health systems which must decide which drugs to make available and to whom. Few areas of health policy are […] The post How new medicines become available on the NHS appeared first on The Pharmacist.

92
article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

AI-powered orchestration: Bringing the benefits to personalized therapy

Pharmaceutical Technology

Supply chains for a new generation of therapies are complex, costly, and require meticulous management to ensure patient safety and regulatory compliance. AI can transform cell and gene therapy (CGT) orchestration by automating manual processes, improving productivity, enhancing supply chain visibility and improving scalability.

article thumbnail

Novo Nordisk launches Wegovy for chronic weight management and cardiovascular risk reduction in India

Express Pharma

Novo Nordisk, a Denmark-based pharma company with a history of over 100 years in chronic disease care, has launched Wegovy (injectable semaglutide) in India. Wegovy is a once-weekly glucagon-like peptide-1 receptor agonist (GLP-1 RA) and is the first medication in India indicated for both long-term chronic weight management and the reduction of major adverse cardiovascular events in people living with obesity or overweight.

article thumbnail

Genentech's Bittenbender named board chair at BIO

pharmaphorum

Genentech's Fritz Bittenbender becomes chair of the Biotechnology Innovation Organization at a challenging time for the sector.

90
article thumbnail

STAT+: U.K. decision blocks a pair of Alzheimer’s drugs from access through its national health service

STAT

LONDON — A U.K. health agency reiterated on Thursday that the limited benefits of a pair of new Alzheimer’s drugs do not justify their high prices, meaning the medicines won’t be made available through the National Health Service. The decision by the U.K.’s cost-effectiveness watchdog reflects how health authorities in different parts of the world have taken different approaches with the drugs, which are the first to have shown they can slow the progression of the dis

article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

FDA to speed reviews for drugs supporting ‘national interests’

BioPharma Dive

A new pilot program announced by FDA Commissioner Martin Makary would award vouchers that could cut drug reviews to one or two months — but only for products that meet a special criteria.

87
article thumbnail

Biogen scores Cannes Festival win with dark humored campaign

PharmaVoice

The company’s unique campaign for a rare, terminal illness nabbed millions of views and a spot on the main stage at the Cannes Lions Festival of Creativity.

130
130
article thumbnail

Glenmark launches TEVIMBRA in India for treatment of advanced lung and oesophageal cancer

Express Pharma

Glenmark Pharmaceuticals, has announced the launch of TEVIMBRA (tislelizumab) in India after receiving regulatory approval from the Central Drugs Standard Control Organisation (CDSCO). This marks Glenmark’s entry into the field of immune-oncology within the country. TEVIMBRA is an anti-PD-1 monoclonal antibody originally developed by BeiGene, which now operates as BeOne Medicines.